Stanford, California Clinical Trials

A listing of Stanford, California clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 175 clinical trials
None
A Study of TAK-079 in People With Generalized Myasthenia Gravis

Myasthenia gravis is an autoimmune condition that causes muscle weakness. Autoimmune means the body makes antibodies that attack its own cells and tissues. These types of antibodies are also known as autoantibodies. People with generalized myasthenia gravis have a weakness in many muscles. TAK-079 is a medicine to help people …

serologic test
immunosuppressive agents
anticholinesterase agents
tacrolimus
corticosteroids
Stanford Neuroscience Health Center
 (3.0 away) Contact site
  • 26 views
  • 02 Apr, 2021
  • +58 other locations
None
Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors

This trial will evaluate safety and efficacy of human engineered T-cell therapies, in participants with advanced tumors.

cyclophosphamide
sarcoma
measurable disease
solid neoplasm
primary cancer
GSK Investigational Site
 (0.2 away) Contact site
  • 4 views
  • 27 Nov, 2021
  • +35 other locations
None
Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma

This phase II trial studies how well reduced doses of radiation therapy to the brain and spine (craniospinal) and chemotherapy work in treating patients with newly diagnosed type of brain tumor called WNT)/Wingless (WNT)-driven medulloblastoma. Recent studies using chemotherapy and radiation therapy have been shown to be effective in treating …

cancer
glomerular filtration rate
vincristine
residual tumor
cyclophosphamide
Lucile Packard Children's Hospital Stanford University
 (1.2 away) Contact site
  • 119 views
  • 27 Oct, 2021
  • +136 other locations
None
PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706

This study consists of 2 parts. Part 1 of the study is conducted to evaluate the efficacy, safety, and tolerability of two doses of K0706 compared to placebo in subjects with early Parkinson's Disease who are not receiving dopaminergic therapy. Part 2 is an optional long term extension study for …

early parkinson's
SPARC Site 45
 (5.0 away) Contact site
  • 150 views
  • 01 Nov, 2021
  • +137 other locations
None
Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients

This is a single arm, open-label, multi-center, phase II study to determine the efficacy and safety of tisagenlecleucel in de novo HR pediatric and young adult B-ALL patients who received first-line treatment and are EOC MRD positive. The study will have the following sequential phases: screening, pre-treatment, treatment & follow-up, …

renal function
methotrexate
flow cytometry
oxygen saturation
gilbert's syndrome
Stanford Universtiy Medical Center
 (1.2 away) Contact site
  • 42 views
  • 15 Nov, 2021
  • +58 other locations
None
(PIONEER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285) A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor Versus Placebo in Patients With Indolent Systemic Mastocytosis

This is a Phase 2, randomized, double-blind, placebo-controlled study comparing the efficacy and safety of avapritinib + best supportive care (BSC) with placebo + BSC in patients with indolent systemic mastocytosis (ISM) whose symptoms are not adequately controlled by BSC. The study will be conducted in 3 parts. All patients …

Stanford Cancer Institute
 (0.3 away) Contact site
  • 47 views
  • 31 Oct, 2021
  • +49 other locations
None
IPH4102 Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma

This is an open label, multi-cohort, and multi-center phase II study, which evaluates the clinical activity and safety of IPH4102 in Sezary Syndrome and Mycosis fungoides as single agent.

skin lesion
mycosis fungoides
sezary syndrome
skin biopsy
peripheral t-cell lymphoma
Stanford Cancer Center
 (0.2 away) Contact site
  • 26 views
  • 12 Jun, 2021
  • +44 other locations
None
HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005

The purpose of this clinical study is to evaluate the safety and efficacy of two doses of GT005 administered as a single subretinal injection in subjects with geographic atrophy secondary to age-related macular degeneration (AMD).

Byers Eye Institute at Stanford
 (3.3 away) Contact site
  • 10 views
  • 07 Nov, 2021
  • +47 other locations
None
A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

The purpose of this study is evaluate the efficacy of teclistamab at the recommended Phase 2 dose (RP2D).

measurable disease
multiple myeloma
Stanford University Medical Center
 (0.3 away) Contact site
  • 0 views
  • 14 Nov, 2021
  • +74 other locations
None
EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005

The purpose of this clinical study is to evaluate the safety and efficacy of two doses of GT005 administered as a single subretinal injection in subjects with geographic atrophy secondary to age-related macular degeneration (AMD).

Byers Eye Institute at Stanford
 (3.3 away) Contact site
  • 57 views
  • 07 Nov, 2021
  • +28 other locations